Cargando…
Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects
CD137-targeting immune therapy, which activates anti-tumor T effector cell responses, seems to be an attractive concept in clinical oncology. Recent evidence has demonstrated that tumor cells besides T cells and antigen-presenting cells are able to express CD137 and CD137L. Here we aimed to identify...
Autores principales: | Grimmig, Tanja, Gasser, Martin, Moench, Romana, Zhu, Lang-Jing, Nawalaniec, Karol, Callies, Simone, Wagner, Martin, Polat, Buelent, Mothi, Suraj Sarvode, Luo, Yueming, Ribas, Carmen M., Malafaia, Osvaldo, Hsiao, Li-Li, Waaga-Gasser, Ana Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844327/ https://www.ncbi.nlm.nih.gov/pubmed/31741755 http://dx.doi.org/10.1080/2162402X.2019.1651622 |
Ejemplares similares
-
Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer
por: Moench, Romana, et al.
Publicado: (2022) -
Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis
por: Grimmig, Tanja, et al.
Publicado: (2017) -
PDE4D targeting enhances anti-tumor effects of sorafenib in clear cell renal cell carcinoma and attenuates MAPK/ERK signaling in a CRAF-dependent manner
por: Cao, Minghua, et al.
Publicado: (2022) -
KMP01D Demonstrates Beneficial Anti-inflammatory Effects on Immune Cells: An ex vivo Preclinical Study of Patients With Colorectal Cancer
por: Gasser, Martin, et al.
Publicado: (2020) -
Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer
por: Grimmig, Tanja, et al.
Publicado: (2016)